Rapid diagnosis of MEN2B using unlabeled probe melting analysis and the LightCycler 480 instrument

Journal of Molecular Diagnostics

Volumn 10, Issue 2, 2008, Pages 123-128

  Margraf, Rebecca L ^a,c   Mao, Rong ^a,b   Wittwer, Carl T ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET; SINGLE STRANDED DNA;

AMPLICON; ARTICLE; CANCER DIAGNOSIS; CODON; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EQUIPMENT; GENE IDENTIFICATION; GENE PROBE; GENETIC ANALYSIS; GENOTYPE; HUMAN; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION;

EID: 41149142605     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2008.070111     Document Type: Article

References (19)

1. Elisei R, Cosci B, Romei C, Agate L, Piampiani P, Miccoli P, Berti P, Basolo F, Ugolini C, Ciampi R, Nikiforov Y, Pinchera A: Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. J Clin Endocrinol Metab 2004, 89:5823-5827
2. Wiesner G, Snow-Bailey K: GeneReviews: Multiple Endocrine Neoplasia Type 2. http://www.geneclinics.org/servlet/access?db=geneclinics&site=gt&id= 8888892&key=2paoNNdpDmi-r&gry=&fcn=y&fw=ZVFB&filename=/ profiles/men2/index.html. Update Mar 7 2005
3. Gimm O, Marsh DJ, Andrew SD, Frilling A, Dahia PL, Mulligan LM, Zajac JD, Robinson BG, Eng C: Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 1997, 82:3902-3904
4. Zhou L, Myers AN, Vandersteen JG, Wang L, Wittwer CT: Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem 2004, 50:1328-1335
5. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT: RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis. J Mol Diagn 2007, 9:184-196
6. Zhou L, Wang L, Palais R, Pryor R, Wittwer CT: High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 2005, 51:1770-1777
7. Liew M, Seipp M, Durtschi J, Margraf RL, Dames S, Erali M, Voelkerding K, Wittwer C: Closed-tube SNP genotyping without labeled probes/a comparison between unlabeled probe and amplicon melting. Am J Clin Pathol 2007, 127:341-348
8. Liew M, Nelson L, Margraf R, Mitchell S, Erali M, Mao R, Lyon E, Wittwer C: Genotyping of human platelet antigens 1 to 6 and 15 by high-resolution amplicon melting and conventional hybridization probes. J Mol Diagn 2006, 8:97-104
9. Herrmann MG, Durtschi JD, Wittwer CT, Voelkerding KV: Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin Chem 2007, 53:1544-1548
10. Hansford JR, Mulligan LM: Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 2000, 37:817-827
11. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT: Mutation scanning of the RET protooncogene using high-resolution melting analysis. Clin Chem 2006, 52:138-141
12. Dames S, Margraf RL, Pattison DC, Wittwer CT, Voelkerding KV: Characterization of aberrant melting peaks in unlabeled probe assays. J Mol Diagn 2007, 9:290-296
13. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN: Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003, 21:577-581
14. Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC: Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Clin Endocrinol (Oxford) 2006, 64:659-666
15. Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO: A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab 2004, 89:3521-3526
16. Fitze G, Cramer J, Ziegler A, Schierz M, Schreiber M, Kuhlisch E, Roesner D, Schackert HK: Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet 2002, 359:1200-1205
17. Seipp MT, Durtschi JD, Liew MA, Williams J, Damjanovich K, Pont-Kingdon G, Lyon E, Voelkerding KV, Wittwer CT: Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. J Mol Diagn 2007, 9:284-289
18. Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PU: Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer 1995, 76:479-489
19. Kitamura Y, Scavarda N, Wells SA Jr , Jackson CE, Goodfellow PJ: Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. Hum Mol Genet 1995, 4:1987-1988